Peixun Zhou

Peixun Zhou

Teesside University

H-index: 6

Europe-United Kingdom

About Peixun Zhou

Peixun Zhou, With an exceptional h-index of 6 and a recent h-index of 6 (since 2020), a distinguished researcher at Teesside University, specializes in the field of Cancer research, Molecular & Cellular Biology, Cytometry & Bioimaging.

His recent articles reflect a diverse array of research interests and contributions to the field:

Confocal Laser Scanning Imaging of Cell Junctions in Human Colon Cancer Cells

Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development

hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia

Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma

Low BACH2 expression predicts adverse outcome in chronic lymphocytic leukaemia

Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis

Abstract PO-19: Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis

DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia

Peixun Zhou Information

University

Position

___

Citations(all)

168

Citations(since 2020)

135

Cited By

46

hIndex(all)

6

hIndex(since 2020)

6

i10Index(all)

5

i10Index(since 2020)

5

Email

University Profile Page

Google Scholar

Peixun Zhou Skills & Research Interests

Cancer research

Molecular & Cellular Biology

Cytometry & Bioimaging

Top articles of Peixun Zhou

Confocal Laser Scanning Imaging of Cell Junctions in Human Colon Cancer Cells

2023/6/14

Peixun Zhou
Peixun Zhou

H-Index: 2

Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development

Acta neuropathologica

2022/9

hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia

Cell Reports Medicine

2022/8/16

Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma

Leukemia

2022/3

Low BACH2 expression predicts adverse outcome in chronic lymphocytic leukaemia

Cancers

2021/12/21

Abstract PO-19: Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis

Blood Cancer Discovery

2020/11

DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia

International Journal of Molecular Sciences

2020/1

See List of Professors in Peixun Zhou University(Teesside University)

Co-Authors

academic-engine